Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers von Lee, Soo-Chin, Shimasaki, Noriko, Lim, Joline S J, Wong, Andrea, Yadav, Kritika, Yong, Wei Peng, Tan, Lip Kun, Koh, Liang Piu, Poon, Michelle L M, Tan, Sing Huang, Ow, Samuel G W, Bharwani, Lavina, Yap, Yoon Sim, Foo, Mabel Z Q, Coustan-Smith, Elaine, Sundar, Raghav, Tan, Hon Lyn, Chong, Wan Qin, Kumarakulasinghe, Nesaretnam Barr, Lieow, Jedidah L M, Koe, Priscillia J X, Goh, Boon Cher, Campana, Dario

Volltext